Cargando…
The Cell Killing Mechanisms of Hydroxyurea
Hydroxyurea is a well-established inhibitor of ribonucleotide reductase that has a long history of scientific interest and clinical use for the treatment of neoplastic and non-neoplastic diseases. It is currently the staple drug for the management of sickle cell anemia and chronic myeloproliferative...
Autores principales: | Singh, Amanpreet, Xu, Yong-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126785/ https://www.ncbi.nlm.nih.gov/pubmed/27869662 http://dx.doi.org/10.3390/genes7110099 |
Ejemplares similares
-
Targeting matrix metallopeptidase 2 by hydroxyurea selectively kills acute myeloid mixed-lineage leukemia
por: Wang, Ruiheng, et al.
Publicado: (2022) -
Hydroxyurea Treatment for Sickle Cell Disease
por: Steinberg, Martin H.
Publicado: (2002) -
Hydroxyurea—The Good, the Bad and the Ugly
por: Musiałek, Marcelina W., et al.
Publicado: (2021) -
Mechanisms of Hydroxyurea-Induced Cellular Senescence: An Oxidative Stress Connection?
por: Kapor, Sunčica, et al.
Publicado: (2021) -
Effective control of sickle cell disease with hydroxyurea therapy
por: Singh, Harminder, et al.
Publicado: (2010)